Patrick Lawler, Certified Financial Planner, Tucker Roeder, Financial Advisor and Jeff Van Siclen, Certified Financial PlannerOnline information, artificial intelligence, and conflicting professional advice can create analysis paralysis. Emotions add complexity for biotechnology, pharmaceutical, and life sciences professionals whose wealth may be tied to employer stock or a product they have spent years developing.
Ultra-high-net-worth families have traditionally relied on family offices to coordinate these financial needs. LRVS Advisory Group believes this approach should also be accessible to high-net-worth individuals.
Through its Family CFO model, LRVS builds long-term relationships, offering a trusted point of contact across clients’ financial lives. It coordinates with estate attorneys, accountants, mortgage brokers, insurance agents, and other professionals so decisions reflect the wider picture. When a question falls outside its expertise, LRVS helps identify the right professional and integrates that advice into the plan.
For biotechnology and life sciences clients, that coordination becomes especially important when professional success changes personal finances. An acquisition or sharp rise in employer stock can create substantial wealth while leaving much of a family’s assets concentrated in the company that also provides its income. Years spent developing a drug or product can make diversification emotionally difficult. LRVS helps clients weigh these decisions against broader financial goals, rather than relying on the company’s prospects alone.
“We want to be the first phone call for clients when there’s a question or a problem,” explains Tucker Roeder, financial advisor, describing the firm’s aim of offering direct guidance or connecting clients with the right source of advice.
A Financial Plan That Evolves
The work starts before investing, with a plan covering short-, mid-, and long-term goals, resources, equity, family priorities, workplace benefits, and safeguards for unforeseen events. LRVS builds a roadmap for company stock and other assets, revisiting workplace retirement options and deferred compensation as careers change while addressing diversification, taxes, and retirement needs.
For biotechnology professionals subject to restricted trading windows, LRVS may incorporate 10b5-1 plans into the broader financial strategy. Establishing predetermined sale parameters during permitted periods can help clients begin diversifying concentrated company equity without making each decision in response to short-term price movements. The proceeds can then be evaluated against objectives already established in the financial plan.
The plan evolves with clients’ lives. LRVS holds semiannual reviews and a deeper annual assessment of goals and progress, while remaining available between meetings when personal, professional, or tax developments arise. A child may approach college, company shares may rise sharply, or a new workplace benefit may change a strategy’s value. LRVS also reaches out when market, industry, or tax developments could affect clients.
Continuity extends into retirement. LRVS helps clients define the life they want, quantify their needs, identify durable income sources such as Social Security, pensions, annuities, and rental income, and use investments to address the income gap. It also considers portfolio risk and tax strategies, including the balance between pre-tax and Roth assets, so clients can pursue retirement with greater confidence.
-
We want to be the first phone call for clients when they have a question, a problem, or something they want to solve, providing the right advice or connecting them to the best answer.
Continuity extends into retirement. LRVS helps clients define the life they want, quantify their needs, identify durable income sources such as Social Security, pensions, annuities, and rental income, and use investments to address the income gap. It also considers portfolio risk and tax strategies, including the balance between pre-tax and Roth assets, so clients can pursue retirement with greater confidence.
Clarity That Leads to Decisions
Education sits at the center of this relationship. LRVS is not the financial decider: it presents facts, explains the pros and cons of available choices, and gives clients the context to decide for themselves and their families. Trust, in the firm’s view, is earned through competence, results, communication, and shared participation over time.
The following case illustrates why that approach matters. A client had accumulated company stock for years at a publicly traded company but knew his finances had become complicated. He initially met with LRVS but did not move forward, as competing professional responsibilities and growing family demands made it difficult to prioritize his financial planning. Two years later, a liquidation event arose, and his stock was worth more than $1 million. LRVS helped accelerate his financial plan around taxes, debt, goals, and the substantial equity position. The outcome was favorable, but the client and his wife recognized that earlier action could have reduced the taxes he paid.
Recognized as a Top Biotech Wealth Management Solution 2026, LRVS continues to serve clients whose financial needs extend beyond traditional investment advice. The firm plans to deepen partnerships with accounting and estate planning professionals, expand into new regions, and bring its approach to employees of benefit-rich corporations beyond biotechnology, pharmaceuticals, and life sciences.
By serving as a trusted point of contact through life’s financial turning points, LRVS aims to give clients confidence that their wealth is working in concert with the life they want to build.
Managing Biotech Wealth Beyond Company Stock
A biotech executive can spend years building a company's value while accumulating a personal fortune tied almost entirely to its stock. An acquisition may suddenly make that wealth accessible, but the resulting tax liability can complicate plans to diversify. A disappointing clinical development can produce the opposite result. Wealth management for life sciences professionals must account for this concentration of financial risk, particularly when employment income depends on the same company.
Equity compensation is therefore a defining factor in selecting an advisory firm. Restricted stock and employee stock options introduce decisions that ordinary portfolio management may not adequately address. Vesting schedules can affect when assets become available, while trading restrictions may limit when executives can sell shares. A substantial position can develop gradually without any deliberate decision to concentrate wealth. Buyers should examine whether an advisor understands these arrangements and can develop a systematic approach to diversification.
Tax planning adds complexity to those decisions. Selling a concentrated position can generate substantial capital gains, yet retaining it indefinitely leaves personal finances exposed to one company's performance. The timing of sales matters. Executives subject to insider trading restrictions may also need structured trading arrangements that permit transactions under applicable securities rules. An advisor should be able to coordinate equity decisions with tax professionals and explain the consequences of alternative sale schedules. The objective is to establish a realistic path toward diversification without allowing tax considerations alone to dictate investment decisions.
Financial planning becomes more demanding when professional circumstances change quickly. An acquisition can alter compensation arrangements and accelerate decisions about existing equity. A promotion may introduce deferred compensation opportunities that were previously unavailable or unsuitable. Buyers should consider how an advisory firm reviews employer benefits alongside household finances rather than treating workplace compensation separately from investment planning.
Regular reassessment is important, although scheduled meetings cannot anticipate every development. Significant changes in share prices or employment terms may require decisions between reviews. Advisors should provide an accessible process for discussing these events before clients make commitments with lasting financial consequences.
“LRVS Advisory Group develops financial plans before making investment decisions, then creates tax-conscious strategies for managing concentrated equity positions and diversifying company stock.”
Retirement planning presents a related challenge. Professionals whose wealth is concentrated in company shares may need to convert irregular investment gains into dependable future income. That involves estimating spending requirements and determining how much can reasonably come from assets exposed to market fluctuations. Increasingly, retirement may also involve consulting arrangements or reduced working hours rather than an immediate departure from employment. Planning should accommodate those possibilities without assuming a fixed retirement date.
Coordination across financial disciplines is particularly relevant for executives whose decisions involve complex tax exposure. Estate attorneys and accountants may each address a particular matter, but conflicting recommendations can complicate implementation. Buyers should examine whether their advisor can coordinate these specialists around an established financial plan.
LRVS Advisory Group develops financial plans before making investment decisions, then creates tax-conscious strategies for managing concentrated equity positions and diversifying company stock. Its approach includes Rule 10b5-1 trading plans for eligible executives facing restricted trading windows. Through its family CFO model, the firm coordinates financial decisions with accounting and estate planning professionals while maintaining scheduled six-month reviews and additional discussions when circumstances change. It also examines employer benefits and develops retirement income strategies suited to individual timelines. For biotech executives whose compensation and personal wealth remain closely connected to company performance, LRVS Advisory Group merits consideration for its coordinated planning approach.
...Read more
